The Global Health Investment Corporation (GHIC) is a health impact venture firm focused on investing in transformational technologies and products that will enable a healthier world and safer future for all. A pioneer of impact investing in global health, GHIC has been financing innovation for nearly a decade.
For nearly a decade, the Global Health Investment Corporation (GHIC) has been financing innovations in healthcare and life sciences. We pursue a double bottom line investment model to accelerate the development of technologies with the potential to both improve public health and generate financial returns. We strive to ensure that the technologies we support will be developed and made accessible to people who need them.
The COVID-19 pandemic clearly demonstrates how interconnected health outcomes are throughout the world. But it is just the latest example. Outbreaks of existing and emerging infectious diseases are inevitable, but we must stop them from becoming pandemics. Our goal is to address today’s global health and health security challenges, anticipate those of tomorrow, and invest in innovations that will lead to a healthier and safer world—for all of us.
Our new global health security venture fund will be launched in partnership with BARDA, which is providing funding to GHIC of up to $500M over 10 years to accelerate the development and commercialization of technologies to address global public health emergencies, such as pandemics and other health security threats.
GHIC is growing its team to become the preeminent health impact platform and scaling across a number of roles to support the expansion of its investment portfolio and other programmatic activities.